Bioactive Compounds Analysis in Osmanthus Fragrans

Osmanthus fragrans, prized for its distinctive fragrance and longstanding use in traditional medicine, has attracted considerable interest as a source of bioactive compounds. Phytochemical investigations have revealed a diverse array of secondary metabolites, including phenylethanoid glycosides, flavonoids, terpenes and glycolipids, many of which exhibit potent antioxidant, anti-inflammatory and enzyme-inhibitory activities. Analytical strategies commonly combine solvent extraction with chromatographic separation (such as high-performance liquid chromatography) and advanced mass spectrometry techniques to achieve both qualitative profiling and quantitative determination. Contemporary studies have explored the stability of heat-sensitive constituents, characterised degradation pathways under varied storage conditions and assessed pharmacological efficacy in cellular and in vivo models. This field continues to expand through integrated approaches that link compound identification to mechanistic bioassays, underscoring the global significance of O. fragrans extracts in nutraceutical, pharmaceutical and functional food applications.

Research from Nature Portfolio

Recent analyses have elucidated the thermal, photochemical and pH-dependent stability of major phenylethanoid glycosides in O. fragrans flowers. By combining ultra-performance liquid chromatography with high-resolution mass spectrometry, researchers mapped the first-order kinetics of acteoside and salidroside degradation and identified key hydrolysis products—among them tyrosol and caffeic acid. Functional assays revealed that the anti-hypoxia efficacy of degraded glycosides diminishes proportionately with parent compound loss, although certain breakdown products may retain or exceed original activity in neuronal cell models.

Investigations into isolated constituents have demonstrated that specific fatty acids and structurally related cyclic ketones from O. fragrans can inhibit carbohydrate-digesting enzymes (α-amylase and α-glucosidase), curb formation of advanced glycation end products and attenuate oxidative stress. In comparative enzyme assays, selected octadecadienoic and octadecatrienoic acids outperformed standard inhibitors, highlighting their potential contribution to glycaemic control and mitigation of diabetic pathology.

Bioactive Compounds Analysis in Osmanthus Fragrans publication trend

The graph below shows the total number of articles in bioactive compounds analysis in osmanthus fragrans across all publications each year (not limited to Nature Index journals).

Technical terms

Phenylethanoid glycosides (PhGs): Plant-derived phenolic compounds in which a phenylethanoid moiety is glycosidically linked to sugars, noted for antioxidant and neuroprotective effects.

Glycolipids: Lipid molecules covalently bonded to carbohydrate groups, here associated with modulation of immune receptor activity and anti-inflammatory properties.

α-Glucosidase: An intestinal enzyme responsible for cleaving terminal glucose residues from carbohydrates; inhibition delays postprandial glucose absorption.

Advanced glycation end products (AGEs): Irreversible adducts formed by non-enzymatic reactions of reducing sugars with proteins or lipids, contributing to diabetic complications and tissue damage.

High-performance liquid chromatography (HPLC): A separation technique using high-pressure solvent flow through a stationary phase to resolve and quantify analytes in complex mixtures.

Liquid chromatography–high-resolution mass spectrometry (LC-HRMS): An analytical method that unites chromatographic separation with precise mass measurement, permitting accurate identification and quantification of natural products.

References

1. Degradation of phenylethanoid glycosides in Osmanthus fragrans Lour. flowers and its effect on anti-hypoxia activity. Scientific Reports (2017).
2. Inhibitory Potential of Constituents from Osmanthus fragrans and Structural Analogues Against Advanced Glycation End Products, α-Amylase, α-Glucosidase, and Oxidative Stress. Scientific Reports (2017).
3. Glycolipid-enriched fraction of Osmanthus fragrans inhibits LPS-induced expression of inflammatory genes, COX-2, E-selectin, and Interleukin-8. Journal of Ethnopharmacology (2023).
4. Secondary Metabolites of Osmanthus fragrans: Metabolism and Medicinal Value. Frontiers in Pharmacology (2022).
5. Antioxidant, Anti-Inflammatory and Antiproliferative Effects of Osmanthus fragrans (Thunb.) Lour. Flower Extracts. Plants (2023).